ArticleFrontiers in endocrinology2026
Analysis of the trajectory of depressive symptoms and influencing factors in patients undergoing metabolic and bariatric surgery.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aims: This study aims to investigate the factors influencing depressive symptoms both before and after metabolic and bariatric surgery (MBS) in obese patients, as well as to analyze the contributing factors to heterogeneous subgroups with distinct depression trajectories. Methods: This study enrolled 184 obese patients who underwent MBS at Changzhou Second People's Hospital between October 2023 and October 2024. Body composition and clinical laboratory data were obtained preoperatively, as well as at 1 month, 3 months, and 6 months postoperatively. The 9-item patient health questionnaire was used to assess the severity of depressive symptoms. Results: Depressive scores showed a significant decrease at 1 month, 3 months, and 6 months postoperatively. Multiple linear regression indicated that anxiety consistently served as a risk factor for the development of depression in MBS patients, while higher medication adherence, vitality, role emotional, and resting potential scores acted as protective factors against depression progression. Growth mixture model analysis identified two heterogeneous subgroups in the depression trajectories of MBS patients. Binary logistic regression revealed that patients with comorbid hypertension and low health transition scores exhibited lower preoperative depression levels and were more likely to belong to the "mild depression decline group". In contrast, patients with comorbid anxiety, low medication adherence, and high vitamin B12 levels showed higher preoperative depression levels and tended to belong to the "significant depression decline group". Conclusions: Patients with anxiety disorder are prone to developing depression after MBS. Patients with comorbid anxiety, low medication adherence, and high vitamin B12 levels exhibit higher preoperative depression severity and require particular attention. However, their postoperative depression levels decreased significantly, highlighting the importance of postoperative follow-up for effective emotional management in this subgroup.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.